Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 43
- −2 vs. Q1 2025
- Portfolio value
- $89.5M
- +$2.59M (+3.0%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Nushares ETF Tr67092P300 | NUVEEN ESG LRGVL | 345,887 | $14.5M | 16.2% | −209,125−37.7% | Reduced | – |
| iShares MSCI USA Momentum Factor ETF46432F396 | ETF | 40,843 | $9.82M | 11.0% | −928−2.2% | Reduced | – |
| Vanguard Ftse Emerging Markets ETF922042858 | ETF | 172,044 | $8.51M | 9.5% | +15,160+9.7% | Added | – |
| iShares Tr46435G516 | ESG AW MSCI EAFE | 72,693 | $6.49M | 7.2% | +72,693 | New | – |
| Vanguard Ftse Developed Markets ETF921943858 | ETF | 110,174 | $6.28M | 7.0% | +886+0.8% | Added | – |
| DBX ETF Tr233051200 | XTRACK MSCI EAFE | 126,874 | $5.55M | 6.2% | +19,719+18.4% | Added | – |
| iShares Inc46434G863 | ESG AWR MSCI EM | 140,414 | $5.50M | 6.1% | +140,414 | New | – |
| iShares Core High Dividend ETF46429B663 | ETF | 41,996 | $4.92M | 5.5% | −1,112−2.6% | Reduced | – |
| iShares MSCI USA Min Vol Factor ETF46429B697 | ETF | 45,174 | $4.24M | 4.7% | −75−0.2% | Reduced | – |
| Vanguard Morningstar Value ETF922908744 | ETF | 16,391 | $2.90M | 3.2% | +2,057+14.4% | Added | – |
| iShares Core S&P 500 ETF464287200 | ETF | 4,419 | $2.74M | 3.1% | −162−3.5% | Reduced | – |
| NVDANVIDIA Corp | Stock | 14,852 | $2.35M | 2.6% | −133−0.9% | Reduced | History |
| Vanguard Morningstar Small-Cap ETF922908751 | ETF | 9,503 | $2.25M | 2.5% | +5,248+123.3% | Added | – |
| iShares Inc46434G509 | CUR HD MSCI EM | 64,057 | $1.93M | 2.2% | −152−0.2% | Reduced | – |
| SPYSPDR S&P 500 ETF Trust | ETF | 2,746 | $1.70M | 1.9% | +9+0.3% | Added | History |
| WisdomTree Tr97717W562 | US SMALLCAP FUND | 20,571 | $1.05M | 1.2% | −5,435−20.9% | Reduced | – |
| JPMJPMorgan Chase & Co | Stock | 3,321 | $963.0K | 1.1% | −39−1.2% | Reduced | History |
| First Tr Exchange-Traded FD33738D101 | NO AMER ENERGY | 18,970 | $712.0K | 0.8% | +5,688+42.8% | Added | – |
| Vanguard World FD921910709 | EXTENDED DUR | 9,389 | $632.0K | 0.7% | +9,389 | New | – |
| iShares Tr464288661 | 3 7 YR TREAS BD | 5,119 | $610.0K | 0.7% | +3,268+176.6% | Added | – |
| DEDeere & Co | Stock | 1,126 | $572.0K | 0.6% | +4+0.4% | Added | History |
| iShares MSCI India ETF46429B598 | ETF | 7,426 | $413.5K | 0.5% | 00.0% | Unchanged | – |
| ProShares Tr74347R107 | PSHS ULT S&P 500 | 4,050 | $395.8K | 0.4% | +8+0.2% | Added | – |
| ABTAbbott Laboratories | Stock | 2,893 | $393.5K | 0.4% | +2,893 | New | History |
| MDTMedtronic plc | Stock | 4,333 | $377.7K | 0.4% | +1,332+44.4% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 891 | $361.1K | 0.4% | +367+70.0% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 4,445 | $347.6K | 0.4% | −526−10.6% | Reduced | History |
| INCYIncyte Corp | COM | 5,094 | $346.9K | 0.4% | +1,724+51.2% | Added | History |
| PFEPfizer Inc | Stock | 13,428 | $325.5K | 0.4% | +4,777+55.2% | Added | History |
| ProShares Tr74347R842 | PSHS ULTRUSS2000 | 7,907 | $297.9K | 0.3% | +20+0.3% | Added | – |
| iShares Tips Bond ETF464287176 | ETF | 2,452 | $270.0K | 0.3% | −522−17.6% | Reduced | – |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 490 | $257.1K | 0.3% | +490 | New | History |
| PMPhilip Morris International Inc. | Stock | 1,413 | $257.0K | 0.3% | +12+0.9% | Added | History |
| iShares Tr464288513 | IBOXX HI YD ETF | 3,183 | $257.0K | 0.3% | +3,183 | New | – |
| iShares Tr464288372 | GLB INFRASTR ETF | 3,905 | $231.0K | 0.3% | −2,903−42.6% | Reduced | – |
| UNHUnitedHealth Group Inc | Stock | 734 | $229.0K | 0.3% | −86−10.5% | Reduced | History |
| iShares Iboxx $ Investment Grade Corporate Bond ETF464287242 | ETF | 1,975 | $216.0K | 0.2% | +1,975 | New | – |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 63,985 | $67.2K | 0.1% | −44,323−40.9% | Reduced | History |
| ANNXAnnexon, Inc. | COM | 27,575 | $66.2K | 0.1% | −1,016−3.6% | Reduced | History |
| CTMXCytomX Therapeutics, Inc. | COM | 27,698 | $62.9K | 0.1% | −72,372−72.3% | Reduced | History |
| MREOMereo BioPharma Group plc | SPON ADS | 19,138 | $51.9K | 0.1% | −28,492−59.8% | Reduced | History |
| GERNGeron Corp | COM | 35,181 | $49.6K | 0.1% | −27,792−44.1% | Reduced | History |
| NKTXNkarta, Inc. | COM | 27,979 | $46.4K | 0.1% | −1,212−4.2% | Reduced | History |
Sold out since Q1 2025 (9)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| SPDR Series Trust78468R796 | ST STR SP500FF | 203,859 | $9.33M | 10.7% | – |
| PIMCO ETF Tr72201R304 | 15+ YR US TIPS | 7,394 | $405.0K | 0.5% | – |
| LEGNLegend Biotech Corp | SPONSORED ADS | 6,429 | $218.6K | 0.3% | History |
| DJPBarclays Bank PLC | DJUBS CMDT ETN36 | 6,120 | $216.0K | 0.2% | History |
| iShares Tr464287440 | 7-10 YR TRSY BD | 2,196 | $209.0K | 0.2% | – |
| Invesco Exch Traded FD Tr II46138G508 | SR LN ETF | 9,786 | $203.0K | 0.2% | – |
| COGTCogent Biosciences, Inc. | COM | 14,015 | $83.5K | 0.1% | History |
| IMTXImmatics N.V. | SHS | 15,971 | $71.8K | 0.1% | History |
| ITOSiTeos Therapeutics, Inc. | COM | 11,061 | $66.4K | 0.1% | History |